Sort   by:  
 Page size 
UnknownRandomized Phase II Evaluation of Bevacizumab Versus Bevacizumab Plus Fosbretabulin in Recurrent Ovarian, Tubal, or Peritoneal Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
Not available
S-EPMC4962710 | biostudies-literature
UnknownSOLLID - a single centre study to develop methods to investigate the effects of low radiation doses within nuclear medicine, to enable multicentre epidemiological investigations.
Not available
S-EPMC8011250 | biostudies-literature
UnknownSELIMETRY-a multicentre I-131 dosimetry trial: a clinical perspective.
Not available
S-EPMC5605100 | biostudies-literature
UnknownInvestigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial.
Not available
S-EPMC6567392 | biostudies-literature
UnknownQuality of life during and following sequential treatment of previously untreated patients with multiple myeloma: findings of the Medical Research Council Myeloma IX randomised study.
Not available
S-EPMC6175065 | biostudies-literature
UnknownNeutral tumor evolution in myeloma is associated with poor prognosis.
Not available
S-EPMC5630010 | biostudies-literature
UnknownPrognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation.
Not available
S-EPMC2948096 | biostudies-literature
UnknownTranscriptome-wide association study of multiple myeloma identifies candidate susceptibility genes.
Not available
S-EPMC6700979 | biostudies-literature
UnknownMutation and association analysis of GEN1 in breast cancer susceptibility.
Not available
S-EPMC3632835 | biostudies-literature
UnknownGermline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.
Not available
S-EPMC3785128 | biostudies-literature
Sort   by:  
 Page size